Click for best price
Personalized Medicine for Cancer Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Personalized Medicine for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicine for Cancer. This report contains market size and forecasts of Personalized Medicine for Cancer in global, including the following market information:
Global Personalized Medicine for Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Personalized Medicine for Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Immunotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Personalized Medicine for Cancer include Bayer, GlaxoSmithKline, Novartis, Sanofi, Pfizer, Amgen, Merck, Bristol-Myers Squibb and Ariad Pharmaceuticals (Takeda), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Personalized Medicine for Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Personalized Medicine for Cancer Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Personalized Medicine for Cancer Market Segment Percentages, by Type, 2022 (%)
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others
Global Personalized Medicine for Cancer Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Personalized Medicine for Cancer Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others
Global Personalized Medicine for Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Personalized Medicine for Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Personalized Medicine for Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Personalized Medicine for Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Ariad Pharmaceuticals (Takeda)
Eli Lilly
Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Personalized Medicine for Cancer, market overview.
Chapter 2: Global Personalized Medicine for Cancer market size in revenue.
Chapter 3: Detailed analysis of Personalized Medicine for Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Personalized Medicine for Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Personalized Medicine for Cancer Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Personalized Medicine for Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Personalized Medicine for Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Personalized Medicine for Cancer Overall Market Size
2.1 Global Personalized Medicine for Cancer Market Size: 2022 VS 2029
2.2 Global Personalized Medicine for Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Personalized Medicine for Cancer Players in Global Market
3.2 Top Global Personalized Medicine for Cancer Companies Ranked by Revenue
3.3 Global Personalized Medicine for Cancer Revenue by Companies
3.4 Top 3 and Top 5 Personalized Medicine for Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Personalized Medicine for Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalized Medicine for Cancer Players in Global Market
3.6.1 List of Global Tier 1 Personalized Medicine for Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Personalized Medicine for Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Personalized Medicine for Cancer Market Size Markets, 2022 & 2029
4.1.2 Immunotherapy
4.1.3 Targeted Therapy
4.1.4 Chemotherapy
4.1.5 Hormone Therapy
4.1.6 Others
4.2 By Type - Global Personalized Medicine for Cancer Revenue & Forecasts
4.2.1 By Type - Global Personalized Medicine for Cancer Revenue, 2018-2023
4.2.2 By Type - Global Personalized Medicine for Cancer Revenue, 2024-2029
4.2.3 By Type - Global Personalized Medicine for Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Personalized Medicine for Cancer Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Blood Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Skin Cancer
5.1.7 Lung Cancer
5.1.8 Others
5.2 By Application - Global Personalized Medicine for Cancer Revenue & Forecasts
5.2.1 By Application - Global Personalized Medicine for Cancer Revenue, 2018-2023
5.2.2 By Application - Global Personalized Medicine for Cancer Revenue, 2024-2029
5.2.3 By Application - Global Personalized Medicine for Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Personalized Medicine for Cancer Market Size, 2022 & 2029
6.2 By Region - Global Personalized Medicine for Cancer Revenue & Forecasts
6.2.1 By Region - Global Personalized Medicine for Cancer Revenue, 2018-2023
6.2.2 By Region - Global Personalized Medicine for Cancer Revenue, 2024-2029
6.2.3 By Region - Global Personalized Medicine for Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Personalized Medicine for Cancer Revenue, 2018-2029
6.3.2 US Personalized Medicine for Cancer Market Size, 2018-2029
6.3.3 Canada Personalized Medicine for Cancer Market Size, 2018-2029
6.3.4 Mexico Personalized Medicine for Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Personalized Medicine for Cancer Revenue, 2018-2029
6.4.2 Germany Personalized Medicine for Cancer Market Size, 2018-2029
6.4.3 France Personalized Medicine for Cancer Market Size, 2018-2029
6.4.4 U.K. Personalized Medicine for Cancer Market Size, 2018-2029
6.4.5 Italy Personalized Medicine for Cancer Market Size, 2018-2029
6.4.6 Russia Personalized Medicine for Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Personalized Medicine for Cancer Market Size, 2018-2029
6.4.8 Benelux Personalized Medicine for Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Personalized Medicine for Cancer Revenue, 2018-2029
6.5.2 China Personalized Medicine for Cancer Market Size, 2018-2029
6.5.3 Japan Personalized Medicine for Cancer Market Size, 2018-2029
6.5.4 South Korea Personalized Medicine for Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Personalized Medicine for Cancer Market Size, 2018-2029
6.5.6 India Personalized Medicine for Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Personalized Medicine for Cancer Revenue, 2018-2029
6.6.2 Brazil Personalized Medicine for Cancer Market Size, 2018-2029
6.6.3 Argentina Personalized Medicine for Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Personalized Medicine for Cancer Revenue, 2018-2029
6.7.2 Turkey Personalized Medicine for Cancer Market Size, 2018-2029
6.7.3 Israel Personalized Medicine for Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Personalized Medicine for Cancer Market Size, 2018-2029
6.7.5 UAE Personalized Medicine for Cancer Market Size, 2018-2029
7 Personalized Medicine for Cancer Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Personalized Medicine for Cancer Major Product Offerings
7.1.4 Bayer Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Personalized Medicine for Cancer Major Product Offerings
7.2.4 GlaxoSmithKline Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Personalized Medicine for Cancer Major Product Offerings
7.3.4 Novartis Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Personalized Medicine for Cancer Major Product Offerings
7.4.4 Sanofi Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Personalized Medicine for Cancer Major Product Offerings
7.5.4 Pfizer Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Personalized Medicine for Cancer Major Product Offerings
7.6.4 Amgen Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Personalized Medicine for Cancer Major Product Offerings
7.7.4 Merck Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Major Product Offerings
7.8.4 Bristol-Myers Squibb Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Ariad Pharmaceuticals (Takeda)
7.9.1 Ariad Pharmaceuticals (Takeda) Company Summary
7.9.2 Ariad Pharmaceuticals (Takeda) Business Overview
7.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Major Product Offerings
7.9.4 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.9.5 Ariad Pharmaceuticals (Takeda) Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Personalized Medicine for Cancer Major Product Offerings
7.10.4 Eli Lilly Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 Roche
7.11.1 Roche Company Summary
7.11.2 Roche Business Overview
7.11.3 Roche Personalized Medicine for Cancer Major Product Offerings
7.11.4 Roche Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.11.5 Roche Key News & Latest Developments
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Company Summary
7.12.2 Boehringer Ingelheim Business Overview
7.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Major Product Offerings
7.12.4 Boehringer Ingelheim Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.12.5 Boehringer Ingelheim Key News & Latest Developments
7.13 Johnson and Johnson
7.13.1 Johnson and Johnson Company Summary
7.13.2 Johnson and Johnson Business Overview
7.13.3 Johnson and Johnson Personalized Medicine for Cancer Major Product Offerings
7.13.4 Johnson and Johnson Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.13.5 Johnson and Johnson Key News & Latest Developments
7.14 Teva Pharmaceuticals
7.14.1 Teva Pharmaceuticals Company Summary
7.14.2 Teva Pharmaceuticals Business Overview
7.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Major Product Offerings
7.14.4 Teva Pharmaceuticals Personalized Medicine for Cancer Revenue in Global Market (2018-2023)
7.14.5 Teva Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Personalized Medicine for Cancer Market Opportunities & Trends in Global Market
Table 2. Personalized Medicine for Cancer Market Drivers in Global Market
Table 3. Personalized Medicine for Cancer Market Restraints in Global Market
Table 4. Key Players of Personalized Medicine for Cancer in Global Market
Table 5. Top Personalized Medicine for Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Personalized Medicine for Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Personalized Medicine for Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Personalized Medicine for Cancer Product Type
Table 9. List of Global Tier 1 Personalized Medicine for Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Personalized Medicine for Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Personalized Medicine for Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Personalized Medicine for Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Personalized Medicine for Cancer Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Personalized Medicine for Cancer Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Personalized Medicine for Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Personalized Medicine for Cancer Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Personalized Medicine for Cancer Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Personalized Medicine for Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Personalized Medicine for Cancer Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Personalized Medicine for Cancer Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Personalized Medicine for Cancer Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Personalized Medicine for Cancer Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Personalized Medicine for Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Personalized Medicine for Cancer Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Personalized Medicine for Cancer Product Offerings
Table 32. Bayer Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Personalized Medicine for Cancer Product Offerings
Table 36. GlaxoSmithKline Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Personalized Medicine for Cancer Product Offerings
Table 40. Novartis Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Personalized Medicine for Cancer Product Offerings
Table 44. Sanofi Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Personalized Medicine for Cancer Product Offerings
Table 48. Pfizer Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Personalized Medicine for Cancer Product Offerings
Table 52. Amgen Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Personalized Medicine for Cancer Product Offerings
Table 56. Merck Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Personalized Medicine for Cancer Product Offerings
Table 60. Bristol-Myers Squibb Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. Ariad Pharmaceuticals (Takeda) Company Summary
Table 63. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product Offerings
Table 64. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Ariad Pharmaceuticals (Takeda) Key News & Latest Developments
Table 66. Eli Lilly Company Summary
Table 67. Eli Lilly Personalized Medicine for Cancer Product Offerings
Table 68. Eli Lilly Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 69. Eli Lilly Key News & Latest Developments
Table 70. Roche Company Summary
Table 71. Roche Personalized Medicine for Cancer Product Offerings
Table 72. Roche Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 73. Roche Key News & Latest Developments
Table 74. Boehringer Ingelheim Company Summary
Table 75. Boehringer Ingelheim Personalized Medicine for Cancer Product Offerings
Table 76. Boehringer Ingelheim Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 77. Boehringer Ingelheim Key News & Latest Developments
Table 78. Johnson and Johnson Company Summary
Table 79. Johnson and Johnson Personalized Medicine for Cancer Product Offerings
Table 80. Johnson and Johnson Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 81. Johnson and Johnson Key News & Latest Developments
Table 82. Teva Pharmaceuticals Company Summary
Table 83. Teva Pharmaceuticals Personalized Medicine for Cancer Product Offerings
Table 84. Teva Pharmaceuticals Personalized Medicine for Cancer Revenue (US$, Mn) & (2018-2023)
Table 85. Teva Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Personalized Medicine for Cancer Segment by Type in 2022
Figure 2. Personalized Medicine for Cancer Segment by Application in 2022
Figure 3. Global Personalized Medicine for Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Personalized Medicine for Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Personalized Medicine for Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Personalized Medicine for Cancer Revenue in 2022
Figure 8. By Type - Global Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 9. By Application - Global Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 10. By Type - Global Personalized Medicine for Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 12. By Application - Global Personalized Medicine for Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 14. By Region - Global Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 15. By Country - North America Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 16. US Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 20. Germany Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 21. France Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 28. China Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. India Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 34. Brazil Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Personalized Medicine for Cancer Revenue Market Share, 2018-2029
Figure 37. Turkey Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Personalized Medicine for Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol-Myers Squibb Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eli Lilly Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Roche Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Boehringer Ingelheim Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Johnson and Johnson Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Teva Pharmaceuticals Personalized Medicine for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
